期刊文献+

氟伐他汀治疗高脂血症患者的疗效观察

Observation of Effect of Fluvastatin on the Treatment of Hyperlipemia
原文传递
导出
摘要 目的:探讨氟伐他汀(fluvastatin)治疗高脂血症患者的疗效分析。方法:对50例确诊动脉粥样硬化血脂异常的患者,以氟伐他汀40 mg/d,治疗6个月。用药前后测TC、TG、LDL-C和HDL-C,采用自身对照开放试验对比其疗效。结果:50例患者治疗前后,TC、TG和LDL-C分别降低了10.9%、39.6%和28.2%,HDL-C上升了0.24±0.09 mmol/L,前后对比差异均有统计学意义(P<0.05)。结论:氟伐他汀治疗高脂血症患者具有良好的调脂作用。 Objective:To study the effect of fluvastatin on the treatment of hyperlipemia. Methods:Fifty patients with hyperlipemia were treated with fluvastatin 40 rag,once a day. TC,TG, LDL-C and HDL-C were detected after 6 weeks. Results : After treatment,TC, TG, LDL-C were decreased 10. 9 %, 39. 6 % and 28. 2 %, respectively. Otherwise, HDL-C increased 0.24 ± 0.09 mmol/L, there was significant difference between pre-and post-treatment (P〈0.05). Conclusion: Fluvastatin was safe and effective for hyperlipemia.
出处 《华西医学》 CAS 2009年第1期118-119,共2页 West China Medical Journal
关键词 氟伐他汀 高脂血症 治疗 fluvastatin hyperlipemia treatment
  • 相关文献

参考文献4

二级参考文献38

  • 1徐济民,上海医学,1985年,8卷,20页
  • 2团体著者,中华心血管病杂志,1995年,23卷,429页
  • 3黄震华,上海医学,1994年,17卷,397页
  • 4徐济民,新药与临床,1986年,5卷,115页
  • 5Scandinavian Simvastatin Survival Study Group. Randomised trial cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S).Lancet,1994,344: 1383-1389.
  • 6Downs J R, Clearfield M, Weis S, et al. For the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. JAMA, 1998, 279:1615-1622.
  • 7The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med,1998,339:1349-1357.
  • 8Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the joint international sosciety and federation of cardiology/world health organization task force on standardization of clinical nomenclature. Circulation,1979,59:607-609.
  • 9Byington R P, Jukema J W, Salonen J T. Reduction in cardiovascular events duing pravastatin therapy. Pooled analysis of clinical events of pravastatin atherosclerosis intervention program. Circulation,1995,92:2419-2425.
  • 10Voger R A, Corretti M C, Plotnick G N, et al. Changes in flow mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. Am J Cardiol,1996,77:37-40.

共引文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部